Stockcalc – Free Trial
Have a free look inside the StockCalc website at www.stockcalc.com/registration2.aspx
I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.
Undervalued Stocks on TSX
Today we are looking at companies that are considered undervalued based on the Analyst data in the StockCalc database.
In the table below we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.
There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.
Today’s Data on TSX
Today’s data is for companies listed on the TSX Venture Exchange.
| Symbol | Name | Target Year | Close Price | Target Price Mean | Currency | Target Price # of Estimates |
|---|---|---|---|---|---|---|
| SRX | Storm Resources Ltd | 2017 | 4.160000 | 5.9955 | CAD | 11 |
| WED | Westaim Corp | 2017 | 3.050000 | 4.2000 | CAD | 3 |
| LXE | Leucrotta Exploration Inc | 2017 | 2.330000 | 3.2850 | CAD | 10 |
| OGI | OrganiGram Holdings Inc | 2017 | 2.820000 | 3.8400 | CAD | 5 |
| CKG | Chesapeake Gold Corp | 2017 | 4.030000 | 6.0000 | CAD | 1 |
| LLG | Mason Graphite Inc | 2018 | 1.420000 | 2.3000 | CAD | 2 |
| MPH | Medicure Inc | 2017 | 9.270000 | 11.9833 | CAD | 3 |
| PRB | Probe Metals Inc | 2017 | 1.480000 | 2.3250 | CAD | 2 |
| SOG | Strategic Oil & Gas Ltd | 2017 | 2.860000 | 4.0000 | CAD | 1 |
| AT | AcuityAds Holdings Inc | 2017 | 4.440000 | 6.0833 | CAD | 3 |
| FCF | Founders Advantage Capital Corp | 2017 | 3.300000 | 4.7500 | CAD | 4 |
| RX | Biosyent Inc | 2017 | 7.610000 | 9.1250 | CAD | 2 |
| SIL | SilverCrest Metals Inc | 2017 | 1.970000 | 3.2500 | CAD | 1 |
| BLN | Blackline Safety Corp | 2017 | 3.200000 | 8.2500 | CAD | 1 |
| POE | Pan Orient Energy Corp | 2017 | 1.600000 | 3.2500 | CAD | 1 |
| DAN | Arianne Phosphate Inc | 2017 | 0.890000 | 1.7750 | CAD | 2 |
| M | Mosaic Capital Corp | 2017 | 8.350000 | 10.3333 | CAD | 3 |
| PRN | Profound Medical Corp | 2017 | 0.990000 | 2.9667 | CAD | 3 |
| TTR | Titanium Transportation Group Inc | 2017 | 1.240000 | 2.5000 | CAD | 4 |
| GFG | GFG Resources Inc | 2018 | 1.030000 | 2.1000 | CAD | 1 |
| CBX | Cortex Business Solutions Inc | 2018 | 3.500000 | 6.4167 | CAD | 3 |
| ACST | Acasti Pharma Inc | 2018 | 1.800000 | 10.0000 | CAD | 1 |
| RP | RepliCel Life Sciences Inc | 2017 | 1.040000 | 3.5000 | CAD | 1 |
| EMC | Emblem Corp | 2017 | 2.880000 | 4.0000 | CAD | 4 |
| RNK.A | Wow Unlimited Media Inc | 2017 | 1.510000 | 3.1500 | CAD | 1 |
Let’s look at a few companies…
Lets look at a couple of the companies on this list to get a better understanding of them.
LXE:TSX Leucrotta Exploration
http://www.leucrotta.ca
Leucrotta Exploration has 17 employees and is headquartered in Canada.
Leucrotta Exploration Inc is engaged in the acquisition, development, exploration, and production of oil and natural gas reserves in northeastern British Columbia, Canada.
MPH:TSX Medicure
http://www.medicure.com
Medicure has 39 employees and is headquartered in Canada.
Medicure Inc is a biopharmaceutical company. It is engaged in the research, development and commercialization of human therapeutics. Its products include Aggrastat, Generic aNDA, Transdermal Aggrastat, and Tardoxal.
Free Valuation
Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.
The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.